Veru, Inc. (VERU) Reports Q4 Loss of $0.05/Sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. MSFT
4. PLTR
5. META
6. JNJ
7. CSCO
8. KTOS
9. NVDA
10. QQQ

Go back to Veru, Inc. (VERU) Reports Q4 Loss of $0.05/Sh

Veru Reports Fiscal 2019 Full-Year Net Revenues Doubled, Gross Profit Up 147%

December 12, 2019 6:30 AM EST

--Update on Ongoing Phase 1b/2 VERU-111, Oral Selective Antitubulin, Clinical Trial Demonstrates Antitumor Activity and No Dose Related Toxicity Reached in Men with Metastatic Castration Resistant Prostate Cancer--

--VERU-111 Has Promising Signs of Progression Free Survival--             --Advancing VERU-111 into Three Phase 2 Clinical Studies in Additional Cancer Types--           --Company to Host Investor Conference Call Today at 8 a.m. ET to Discuss Financial Results and Clinical Study Data--

MIAMI, Dec. 12, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:... More